A placebo-controlled trial of buspirone for the treatment of marijuana dependence
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The present study investigated the potential efficacy of buspirone for treating marijuana dependence. Participants received either buspirone (maximum 60 mg/day) (n=23) or matching placebo (n=27) for 12 weeks, each in conjunction with motivational interviewing. In the modified intention-to-treat analysis, the percentage of negative UDS results in the buspirone-treatment group was 18 percentage points higher than the placebo-treatment group (95% CI: −2% to 37%, p=0.071). On self-report, participants receiving buspirone reported not using marijuana 45.2% of days and participants receiving placebo reported not using 51.4% of days (p=0.55). An analysis of participants that completed the 12-week trial showed a significant difference in the percentage negative UDS (95% CI: 7% to 63%, p=0.014) and a trend for participants randomized to the buspirone-treatment group who completed treatment to achieve the first negative UDS result sooner than those participants treated with placebo (p=0.054). Further study with buspirone in this population may be warranted; however, strategies to enhance study retention and improve outcome measurement should be considered in future trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0211 · Cited by 934 · cited 2×
“Another study documented a 28.8% lifetime prevalence of anxiety disorders among those with marijuana use disorders (Conway et al., 2006).”
BackgroundInfluentialAgonistic properties of cannabidiol at 5-HT1a receptors
Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878 · cited 1×
“Cannabidiol (CBD), a major component of cannabis, has been shown to be a modest affinity agonist at the 5-HT1A receptor (Russo et al., 2005).”
BackgroundIncentives Improve Outcome in Outpatient Behavioral Treatment of Cocaine Dependence
Higgins, S. T. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950070060011 · Cited by 806
Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects
Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608
Enhancing motivation for change in problem drinking: a controlled comparison of two therapist styles
Miller, W. R., Benefield, R. G., & Tonigan, J. S. (1993) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.61.3.455 · Cited by 566
Ensuring balanced distribution of prognostic factors in treatment outcome research.
Stout, R. L., Wirtz, P. W., Carbonari, J. P., & Del Boca, F. K. (1994) · Journal of Studies on Alcohol, Supplement · doi:10.15288/jsas.1994.s12.70 · Cited by 461 · cited 1×
“Urn randomization (Stout et al., 1994) was used to determine treatment assignment.”
MethodCannabis use disorders in the USA: prevalence, correlates and co-morbidity
STINSON, F. S., RUAN, W. J., PICKERING, R., & GRANT, B. F. (2006) · Psychological Medicine · doi:10.1017/s0033291706008361 · Cited by 422 · cited 1×
“Lifetime prevalence rates of marijuana abuse and dependence among adults in the United States have been estimated at 7.2 and 1.3%, respectively (Stinson et al., 2006).”
BackgroundInfluentialMarijuana withdrawal among adults seeking treatment for marijuana dependence.
Budney, A. J., Novy, P. L., & Hughes, J. R. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.94913114.x · Cited by 348 · cited 3×
“Weekly assessments included scales to assess marijuana craving (Marijuana Craving Questionnaire (MCQ); Heishman et al., 2001), and marijuana withdrawal symptoms (Marijuana Withdrawal Checklist; Budney et al., 1999).”
BackgroundMethodTreatment of marijuana dependence: a review of the literature.
McRae, A. L., Budney, A. J., & Brady, K. T. (2003) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(03)00041-2 · Cited by 115 · cited 1×
“However, limited research has focused on pharmacological agents in the treatment of marijuana use disorders (McRae et al., 2003; Levin et al., 2004; Nordstrom and Levin, 2007; Tirado et al., 2008).”
BackgroundSelf-citationLevin, F. R., McDowell, D., Evans, S. M., Nunes, E., Akerele, E., Donovan, S., & Vosburg, S. K. (2004) · The American Journal on Addictions · doi:10.1080/10550490490265280 · Cited by 113 · cited 2×
“However, limited research has focused on pharmacological agents in the treatment of marijuana use disorders (McRae et al., 2003; Levin et al., 2004; Nordstrom and Levin, 2007; Tirado et al., 2008).”
Background
Cited by
Hjorthøj, C. R., Hjorthøj, A. R., & Nordentoft, M. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.11.025 · Cited by 364
Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
“In a single controlled trial of buspirone (50 participants), there was a significant difference in favour of buspirone in terms of negative urine drug screens achieved (McRae-Clark et al., 2009) (Ib).”
BackgroundMason, B. J., Crean, R., Goodell, V., Light, J. M., Quello, S., Shadan, F., Buffkins, K., Kyle, M., Adusumalli, M., Begovic, A., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.14 · Cited by 242
Levin, F. R., Mariani, J. J., Brooks, D. J., Pavlicova, M., Cheng, W., & Nunes, E. V. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.12.010 · Cited by 232
Pharmacotherapies for cannabis dependence.
Marshall, K., Gowing, L., Ali, R., & Le Foll, B. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008940.pub2 · Cited by 156
Metadata
- Authors
- McRae-Clark, A. L., Carter, R. E., Killeen, T. K., Carpenter, M. J., Wahlquist, A. E., Simpson, S. A., & Brady, K. T.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 105
- Issue
- 1-2
- Pages
- 132-138
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W2092778523
- Cited by
- 87
- References
- 10
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A placebo-controlled trial of buspirone for the treatment of marijuana dependence. https://app.cochat.ai/papers/10.1016/j.drugalcdep.2009.06.022
- The paper
- McRae-Clark, A. L., Carter, R. E., Killeen, T. K., Carpenter, M. J., Wahlquist, A. E., Simpson, S. A., & Brady, K. T. (2009). A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2009.06.022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.